Diagnostics PCR Market Expected To Reach USD 10.87 billion 2032, is to grow at 4.3% CAGR from 2025-2032

Diagnostics PCR Market size is expected to reach USD 10.87 billion by 2032. The industry is undergoing a transformation driven by increasing demand for durable, high-performance industrial components across various sectors.

Market to Hit USD 10.87 Bn by 2032

Diagnostics PCR Market size was valued at USD 6.21 billion in 2024 and expected to expand at a compound annual growth rate (CAGR) of 4.3% from 2025-2032, reaching USD 10.87 billion by 2032. In 2024, Diagnostics PCR Market Size was valued at approximately USD 3.5 billion in North America and its Market share of 42%. Also, in Europe held a market share of 27.9% in the same year, equating to revenues of USD 2.8 billion in 2024.

Leading market Players Fueling Industry Evolution

In 2024, the Thermo Fisher Scientific (United States) is valued approximately at USD 42.9 billion while Bio-Rad Laboratories (United States) is valued at USD 2.6 billion and Illumina (United States) is valued at USD 4.4 billion respectively in Diagnostics PCR Market.

Reagents and Consumables is dominated by Product Type segment in terms of value, in 2024

This Reagents and Consumables sector dominates the Diagnostics PCR Market which the segment’s market share is 55% in 2023. Reagents encompass essential components such as primers, probes, enzymes, and master mixes that enable DNA amplification and detection.

To know the most attractive segments, click here for a free sample of the report: https://www.stellarmr.com/report/req_sample/Diagnostics-PCR-Market/1361 

Real-Time PCR is dominated by Product Technology segment in terms of value, in 2024

This Real-Time sector dominates the Diagnostics PCR Market which the segment’s value is USD 6.35 billion holding market share 83% of market share in 2024. It offers rapid results and higher sensitivity. Real-time PCR holds the largest market share due to its accurate and quantitative nature, making it suitable for various diagnostic applications. 

North America is estimated to be the largest dominating region in terms of value, during the forecast period

This is the largest region in Diagnostics PCR Market which the valued at approximately USD 3.5 billion in North America and its Market share of 42% in 2024. The region has seen considerable use of PCR-based diagnostic technologies, with a particular emphasis on real-time PCR. 

Europe is estimated to be the Second-largest dominating region in terms of value, during the forecast period

This is the largest region in Diagnostics PCR Market which the valued at approximately USD 2.8 billion in Europe and its Market share of 27.9% in 2024. Europe is another prominent market for Diagnostics PCR, characterized by a robust healthcare sector and a proactive approach towards molecular diagnostics. 

Diagnostics PCR Market Competitive Landscape

Thermo Fisher Scientific: By 2024, this company earns revenue around USD 42.9 billion. Thermo Fisher was granted permission to produce these kits in India by the Central Drugs Standard Control Organization (CDSCO) in February 2023. Thermo Fisher has expanded its autoimmune diagnostics line through an exclusive distribution deal with Aesku Group. 

Illumina: Illumina’s market value is USD 4.4 billion by 2024. Illumina maintained its dominance in NGS technology, providing platforms that enable comprehensive genomic analysis for diagnoses in oncology and genetic disorders. Illumina has won FDA approval for several of its diagnostic assays, cementing its position in the clinical diagnostics sector.

Bio-Rad Laboratories (United States): A leader in life science research and clinical diagnostics, played an important role in expanding PCR technologies and faced a number of market challenges. In 2024, the corporation generated $2.6 billion in revenue. In December 2024, the Royal Bank of Canada boosted its price target for Bio-Rad Laboratories from $369.00 to $481.00 while keeping a “outperform” rating, citing optimism about the company’s strategic efforts and market position.

To know the most attractive segments, click here for a free sample of the report: https://www.stellarmr.com/report/enquire_now/Diagnostics-PCR-Market/1361 

Emerging Trends in the Diagnostics PCR Market

• One major trend is the increasing adoption of digital PCR (PCR) for its high sensitivity and precision, especially in oncology and rare disease detection, with Bio-Rad expanding its footprint in this area. 
• Real-time PCR (qPCR) remains dominant, with Thermo Fisher and Illumina leading advancements in automation and workflow efficiency. There is also a growing shift towards personalized diagnostics with the integration of next-generation sequencing (NGS) and AI-powered platforms for more accurate, individualized patient care. 
• Furthermore, strategic collaborations and global expansion are accelerating, with these companies partnering to enhance their diagnostics portfolios and expand access in emerging markets. 

Conclusion

• Diagnostics PCR market is poised for steady growth, with a projected 4.3% CAGR leading to an estimated market value of USD 10.87 billion by 2032. 
• North America and Europe remain the dominant regions, with companies like Thermo Fisher Scientific, Illumina, and Bio-Rad Laboratories driving innovation and expanding their market presence. 
• The shift towards real-time PCR and digital PCR technologies, alongside advancements in personalized diagnostics and next-generation sequencing, is reshaping the industry. 
• Strategic collaborations, regulatory approvals, and global market expansions will further fuel the evolution of this market, ensuring continued progress in diagnostic capabilities and patient care worldwide.

Related Reports:

Dental Equipment Market https://www.stellarmr.com/report/dental-equipment-market/2436

Epdm Market https://www.stellarmr.com/report/epdm-market/2437

About Stellar Market Research:

Stellar Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.

Contact Stellar Market Research:

S.no.8, h.no. 4-8 Pl.7/4, Kothrud,
Pinnac Memories Fl. No. 3, Kothrud, Pune,
Pune, Maharashtra, 411029
[email protected]